Outset Medical Inc
OM3.420USD
+0.130+3.95%
Market hours （ET）Quotes delayed by 15 min
60.91MMarket Cap
LossP/E TTM
More Details of Outset Medical Inc Company
Outset Medical, Inc. is a medical technology company. It offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. It designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Outset Medical Inc Info
Ticker SymbolOM
Company nameOutset Medical Inc
IPO dateSep 15, 2020
CEOTrigg (Leslie L)
Number of employees354
Security typeOrdinary Share
Fiscal year-endSep 15
Address3052 Orchard Drive
CitySAN JOSE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code95134
Phone16692318200
Websitehttps://outsetmedical.com/
Ticker SymbolOM
IPO dateSep 15, 2020
CEOTrigg (Leslie L)
Company Executives of Outset Medical Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
67.40K
-1.34%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
40.38K
-0.61%
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
22.95K
+64.31%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
10.25K
+706.77%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
7.68K
-16.78%
Mrs. Brittni Mcgill
Mrs. Brittni Mcgill
Chief Nursing Officer
Chief Nursing Officer
--
--
Mr. John L. Brottem
Mr. John L. Brottem
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. D. Keith Grossman
Mr. D. Keith Grossman
Lead Independent Director
Lead Independent Director
--
--
Ms. Andrea L. Saia
Ms. Andrea L. Saia
Independent Director
Independent Director
--
--
Ms. Renee M. Gaeta, CPA
Ms. Renee M. Gaeta, CPA
Chief Financial Officer
Chief Financial Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Leslie L. Trigg
Ms. Leslie L. Trigg
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
67.40K
-1.34%
Mr. Marc Nash
Mr. Marc Nash
Senior Vice President - Operations and Research and Development
Senior Vice President - Operations and Research and Development
40.38K
-0.61%
Mr. Patrick T. (Pat) Hackett
Mr. Patrick T. (Pat) Hackett
Independent Director
Independent Director
22.95K
+64.31%
Mr. Brent D. Lang
Mr. Brent D. Lang
Independent Director
Independent Director
10.25K
+706.77%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
7.68K
-16.78%
Mrs. Brittni Mcgill
Mrs. Brittni Mcgill
Chief Nursing Officer
Chief Nursing Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Consumables
14.15M
45.04%
Consoles
8.93M
28.43%
Services and other revenue
8.34M
26.53%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
14.15M
45.04%
Consoles
8.93M
28.43%
Services and other revenue
8.34M
26.53%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
14.51%
PFM Health Sciences, LP
9.53%
Alyeska Investment Group, L.P.
8.89%
Woodline Partners LP
7.30%
BlackRock Institutional Trust Company, N.A.
6.18%
Other
53.58%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
14.51%
PFM Health Sciences, LP
9.53%
Alyeska Investment Group, L.P.
8.89%
Woodline Partners LP
7.30%
BlackRock Institutional Trust Company, N.A.
6.18%
Other
53.58%
Shareholder Types
Shareholders
Proportion
Hedge Fund
40.40%
Investment Advisor
34.50%
Investment Advisor/Hedge Fund
15.63%
Private Equity
4.59%
Research Firm
2.60%
Individual Investor
2.01%
Venture Capital
0.71%
Corporation
0.61%
Bank and Trust
0.36%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
319
18.96M
106.72%
+1.93M
2025Q2
348
16.26M
91.74%
+11.98M
2025Q1
363
14.91M
84.25%
+11.40M
2024Q4
375
22.97M
42.67%
-34.22M
2024Q3
383
28.58M
54.40%
-41.22M
2024Q2
397
50.60M
97.17%
-19.65M
2024Q1
406
52.26M
101.52%
-18.15M
2023Q4
416
54.21M
107.73%
-7.17M
2023Q3
407
56.98M
114.62%
-11.76M
2023Q2
399
56.04M
113.10%
-11.31M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
2.57M
14.47%
-8.21K
-0.32%
Jun 30, 2025
PFM Health Sciences, LP
1.66M
9.37%
-21.00K
-1.25%
Jun 30, 2025
Alyeska Investment Group, L.P.
1.46M
8.24%
-238.50K
-14.00%
Jun 30, 2025
Woodline Partners LP
1.33M
7.46%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
903.82K
5.09%
+843.90K
+1408.37%
Jun 30, 2025
Durable Capital Partners LP
1.66M
9.33%
-83.09K
-4.77%
Jun 30, 2025
The Vanguard Group, Inc.
991.43K
5.58%
+818.10K
+472.01%
Jun 30, 2025
Perceptive Advisors LLC
833.33K
4.69%
--
--
Jun 30, 2025
MFS Investment Management
636.33K
3.58%
-203.91K
-24.27%
Jun 30, 2025
Parkman Healthcare Partners LLC
549.05K
3.09%
+317.95K
+137.58%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.04%
Avantis US Small Cap Equity ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Date
Type
Ratio
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
Mar 18, 2025
Merger
15→1
FAQs
Who are the top five shareholders of Outset Medical Inc?
The top five shareholders of Outset Medical Inc are:
Fidelity Management & Research Company LLC holds 2.57M shares, accounting for 14.47% of the total shares.
PFM Health Sciences, LP holds 1.66M shares, accounting for 9.37% of the total shares.
Alyeska Investment Group, L.P. holds 1.46M shares, accounting for 8.24% of the total shares.
Woodline Partners LP holds 1.33M shares, accounting for 7.46% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 903.82K shares, accounting for 5.09% of the total shares.
Fidelity Management & Research Company LLC holds 2.57M shares, accounting for 14.47% of the total shares.
PFM Health Sciences, LP holds 1.66M shares, accounting for 9.37% of the total shares.
Alyeska Investment Group, L.P. holds 1.46M shares, accounting for 8.24% of the total shares.
Woodline Partners LP holds 1.33M shares, accounting for 7.46% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 903.82K shares, accounting for 5.09% of the total shares.
What are the top three shareholder types of Outset Medical Inc?
The top three shareholder types of Outset Medical Inc are:
Fidelity Management & Research Company LLC
PFM Health Sciences, LP
Alyeska Investment Group, L.P.
Fidelity Management & Research Company LLC
PFM Health Sciences, LP
Alyeska Investment Group, L.P.
How many institutions hold shares of Outset Medical Inc (OM)?
As of 2025Q3, 319 institutions hold shares of Outset Medical Inc, with a combined market value of approximately 18.96M, accounting for 106.72% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 14.98%.
What is the biggest source of revenue for Outset Medical Inc?
In FY2025Q2, the Consumables business generated the highest revenue for Outset Medical Inc, amounting to 14.15M and accounting for 45.04% of total revenue.
